fda compounding glp-1 enforcement news issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Crackdown Puts Pressure on

GLP-1 medications can be especially relevant in these cases because they affect appetite and glucose-related pathways

Acknowledgements NM acknowledges DST, Rajasthan, for the KARYA Internship opportunity

2011;33(3):473-477 Crommert ME

This is common response rates for topical minoxidil alone are typically 3040%, meaning 6070% of patients see limited benefit

Symptoms include dizziness, weakness, confusion, and irritability

Talking to Your Healthcare Provider About Heart Health If youve been instructed not to use estrogen-based MHT, consider asking a menopause-informed clinician about other ways you can support your cardiovascular health during menopause